🇺🇸 FDA

Company profile · Sponsor

Agomab

Agomab Therapeutics NV

AGMB · NYSE biotech ANTWERPEN, USA
Pipeline
6
Drugs
0
Patents
4

Quick answer

Agomab (AGMB) is a biotech company. headquartered in ANTWERPEN, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker AGMB
Exchange NYSE
Company type biotech
Headquarters ANTWERPEN, USA
SEC CIK 0002020932

Pipeline (6)

Search pipeline →

  1. AGMB-129

    Agomab

    Fibrostenotic Crohn's Disease

    phase 2 small molecule active

    2 trials

  2. A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time

    Agomab

    Fibrostenotic Crohn’s disease

    phase 1 other active

    1 trial

  3. A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).

    Agomab

    liver cirrhosis

    phase 1 other active

    1 trial

  4. AGMB-129

    Agomab

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  5. AGMB-447

    Agomab

    IPF

    phase 1 small molecule active

    1 trial

  6. ORG-129

    Agomab

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Patents (4)

Search patents →

  1. US 12297186

    Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12084504

    Anti-MET antibodies and uses thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11834507

    Anti-MET agonist antibody for use in the treatment of colorectal cancer

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11098126

    Anti-MET antibodies and uses thereof

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Agomab?

Agomab (AGMB) is a biotech company. headquartered in ANTWERPEN, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does Agomab sponsor?

We track 6 ClinicalTrials.gov-linked programs for Agomab, including AGMB-129 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Agomab company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.